HEADER HYDROLASE/HYDROLASE INHIBITOR 09-FEB-17 5UR3 TITLE KAPOSI'S SARCOMA HERPESVIRUS PROTEASE IN COMPLEX WITH ALLOSTERIC TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: KSHV PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 23-215; COMPND 5 SYNONYM: ORF17, ORF 17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 8; SOURCE 3 ORGANISM_COMMON: HHV-8; SOURCE 4 ORGANISM_TAXID: 37296; SOURCE 5 GENE: ORF17; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE HYDROLASE, VIRAL PROTEIN, CAPSID MATURATION, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.M.ACKER,J.GABLE,M.-F.BOHN,C.S.CRAIK REVDAT 4 06-MAR-24 5UR3 1 REMARK REVDAT 3 01-JAN-20 5UR3 1 REMARK REVDAT 2 27-SEP-17 5UR3 1 REMARK REVDAT 1 08-MAR-17 5UR3 0 JRNL AUTH T.M.ACKER,C.S.CRAIK,M.-F.BOHN JRNL TITL KAPOSI'S SARCOMA HERPESVIRUS PROTEASE IN COMPLEX WITH JRNL TITL 2 ALLOSTERIC INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10PRE_2100 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 34879 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 58.6693 - 4.2320 1.00 2704 147 0.1732 0.2106 REMARK 3 2 4.2320 - 3.3591 1.00 2613 124 0.1547 0.1800 REMARK 3 3 3.3591 - 2.9345 1.00 2538 146 0.1756 0.2019 REMARK 3 4 2.9345 - 2.6662 1.00 2559 142 0.1880 0.2452 REMARK 3 5 2.6662 - 2.4751 1.00 2568 129 0.1851 0.2505 REMARK 3 6 2.4751 - 2.3292 1.00 2533 139 0.1868 0.2476 REMARK 3 7 2.3292 - 2.2125 1.00 2548 111 0.1811 0.2616 REMARK 3 8 2.2125 - 2.1162 1.00 2496 154 0.1783 0.2272 REMARK 3 9 2.1162 - 2.0347 1.00 2526 138 0.1823 0.2204 REMARK 3 10 2.0347 - 1.9645 1.00 2510 132 0.1968 0.2439 REMARK 3 11 1.9645 - 1.9031 1.00 2543 123 0.2060 0.2435 REMARK 3 12 1.9031 - 1.8487 0.99 2480 151 0.2238 0.2582 REMARK 3 13 1.8487 - 1.8000 1.00 2500 125 0.2401 0.2870 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 3196 REMARK 3 ANGLE : 1.339 4394 REMARK 3 CHIRALITY : 0.076 501 REMARK 3 PLANARITY : 0.010 568 REMARK 3 DIHEDRAL : 17.155 1883 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UR3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226300. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-SEP-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37258 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 59.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX PHENIX 1.8.4 PHASER 2.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3M IMIDAZOLE PH 8.0, 0.4M REMARK 280 NAH2PO4/1.6M K2HPO4, 0.2M NACL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.70000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.43000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 59.46500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.70000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.43000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.46500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.70000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.43000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.46500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.70000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 46.43000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 59.46500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 363 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 403 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 18 REMARK 465 THR A 195 REMARK 465 LEU A 196 REMARK 465 SER B 124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 ARG A 121 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 125 CG CD OE1 NE2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 ASN B 96 CG OD1 ND2 REMARK 470 LEU B 97 CG CD1 CD2 REMARK 470 ARG B 121 CG CD NE CZ NH1 NH2 REMARK 470 THR B 126 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE ARG A 143 O HOH A 302 1.30 REMARK 500 HH12 ARG A 169 O HOH A 301 1.54 REMARK 500 O HIS B 63 O HOH B 301 1.92 REMARK 500 NH1 ARG A 169 O HOH A 301 1.95 REMARK 500 NE ARG A 143 O HOH A 302 2.06 REMARK 500 OD2 ASP B 12 O HOH B 302 2.16 REMARK 500 NE2 GLN B 125 O HOH B 303 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 303 O HOH B 369 4555 1.88 REMARK 500 O HOH A 365 O HOH B 395 6444 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 85 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG A 143 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 125 -109.16 -93.54 REMARK 500 THR A 146 158.33 77.10 REMARK 500 LEU A 193 24.61 -77.81 REMARK 500 SER B 62 -124.26 48.79 REMARK 500 ASN B 96 -140.03 -103.88 REMARK 500 LEU B 97 50.41 76.45 REMARK 500 SER B 128 -18.47 70.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 11 ASP A 12 149.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8OY A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8OY B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8OY B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4P3H RELATED DB: PDB REMARK 900 4P3H CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 3NJQ RELATED DB: PDB REMARK 900 3NJQ CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 4P2T RELATED DB: PDB REMARK 900 4P2T CONTAINS THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. DBREF 5UR3 A 4 196 UNP O40922 O40922_HHV8 23 215 DBREF 5UR3 B 4 196 UNP O40922 O40922_HHV8 23 215 SEQRES 1 A 193 GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL VAL SER CYS SEQRES 2 A 193 PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP PRO ASP GLN SEQRES 3 A 193 VAL THR ASP TYR LEU PRO VAL THR GLU PRO LEU PRO ILE SEQRES 4 A 193 THR ILE GLU HIS LEU PRO GLU THR GLU VAL GLY TRP THR SEQRES 5 A 193 LEU GLY LEU PHE GLN VAL SER HIS GLY ILE PHE CYS THR SEQRES 6 A 193 GLY ALA ILE THR SER PRO ALA PHE LEU GLU LEU ALA SER SEQRES 7 A 193 ARG LEU ALA ASP THR SER HIS VAL ALA ARG ALA PRO VAL SEQRES 8 A 193 LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU ILE LEU HIS SEQRES 9 A 193 THR TRP LEU PRO GLY LEU SER LEU SER SER ILE HIS PRO SEQRES 10 A 193 ARG GLU LEU SER GLN THR PRO SER GLY PRO VAL PHE GLN SEQRES 11 A 193 HIS VAL SER LEU CYS ALA LEU GLY ARG ARG ARG GLY THR SEQRES 12 A 193 VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP VAL VAL SER SEQRES 13 A 193 ARG PHE SER SER VAL SER LYS SER GLU ARG ALA HIS ILE SEQRES 14 A 193 LEU GLN HIS VAL SER SER CYS ARG LEU GLU ASP LEU SER SEQRES 15 A 193 THR PRO ASN PHE VAL SER PRO LEU GLU THR LEU SEQRES 1 B 193 GLY LEU TYR VAL GLY GLY PHE VAL ASP VAL VAL SER CYS SEQRES 2 B 193 PRO LYS LEU GLU GLN GLU LEU TYR LEU ASP PRO ASP GLN SEQRES 3 B 193 VAL THR ASP TYR LEU PRO VAL THR GLU PRO LEU PRO ILE SEQRES 4 B 193 THR ILE GLU HIS LEU PRO GLU THR GLU VAL GLY TRP THR SEQRES 5 B 193 LEU GLY LEU PHE GLN VAL SER HIS GLY ILE PHE CYS THR SEQRES 6 B 193 GLY ALA ILE THR SER PRO ALA PHE LEU GLU LEU ALA SER SEQRES 7 B 193 ARG LEU ALA ASP THR SER HIS VAL ALA ARG ALA PRO VAL SEQRES 8 B 193 LYS ASN LEU PRO LYS GLU PRO LEU LEU GLU ILE LEU HIS SEQRES 9 B 193 THR TRP LEU PRO GLY LEU SER LEU SER SER ILE HIS PRO SEQRES 10 B 193 ARG GLU LEU SER GLN THR PRO SER GLY PRO VAL PHE GLN SEQRES 11 B 193 HIS VAL SER LEU CYS ALA LEU GLY ARG ARG ARG GLY THR SEQRES 12 B 193 VAL ALA VAL TYR GLY HIS ASP ALA GLU TRP VAL VAL SER SEQRES 13 B 193 ARG PHE SER SER VAL SER LYS SER GLU ARG ALA HIS ILE SEQRES 14 B 193 LEU GLN HIS VAL SER SER CYS ARG LEU GLU ASP LEU SER SEQRES 15 B 193 THR PRO ASN PHE VAL SER PRO LEU GLU THR LEU HET 8OY A 201 58 HET 8OY B 201 58 HET 8OY B 202 58 HETNAM 8OY 4-{[6-(CYCLOHEXYLMETHYL)PYRIDINE-2-CARBONYL]AMINO}-3- HETNAM 2 8OY (PHENYLAMINO)BENZOIC ACID FORMUL 3 8OY 3(C26 H27 N3 O3) FORMUL 6 HOH *224(H2 O) HELIX 1 AA1 ASP A 26 LEU A 34 5 9 HELIX 2 AA2 SER A 73 SER A 87 1 15 HELIX 3 AA3 SER A 87 ALA A 92 1 6 HELIX 4 AA4 GLU A 100 LEU A 110 1 11 HELIX 5 AA5 HIS A 119 SER A 124 1 6 HELIX 6 AA6 ASP A 153 ARG A 160 1 8 HELIX 7 AA7 SER A 165 SER A 178 1 14 HELIX 8 AA8 ASP B 26 LEU B 34 5 9 HELIX 9 AA9 SER B 73 SER B 87 1 15 HELIX 10 AB1 SER B 87 ALA B 92 1 6 HELIX 11 AB2 GLU B 100 LEU B 110 1 11 HELIX 12 AB3 HIS B 119 LEU B 123 5 5 HELIX 13 AB4 ASP B 153 SER B 159 1 7 HELIX 14 AB5 SER B 165 SER B 178 1 14 HELIX 15 AB6 ARG B 180 LEU B 184 5 5 SHEET 1 AA1 9 TYR A 24 LEU A 25 0 SHEET 2 AA1 9 VAL A 149 GLY A 151 0 SHEET 3 AA1 9 GLY A 64 ILE A 71 0 SHEET 4 AA1 9 GLY A 53 VAL A 61 -1 N LEU A 56 O THR A 68 SHEET 5 AA1 9 PRO A 41 ILE A 44 -1 N ILE A 42 O GLY A 53 SHEET 6 AA1 9 PHE A 132 CYS A 138 1 O LEU A 137 N THR A 43 SHEET 7 AA1 9 GLY A 112 SER A 117 -1 N SER A 114 O SER A 136 SHEET 8 AA1 9 LEU A 5 VAL A 14 1 N ASP A 12 O LEU A 115 SHEET 9 AA1 9 VAL A 149 GLY A 151 -1 O GLY A 151 N TYR A 6 SHEET 1 AA2 9 LEU B 23 LEU B 25 0 SHEET 2 AA2 9 ASP B 12 SER B 15 -1 N SER B 15 O LEU B 23 SHEET 3 AA2 9 GLY B 112 SER B 117 1 O LEU B 115 N ASP B 12 SHEET 4 AA2 9 PHE B 132 CYS B 138 -1 O SER B 136 N SER B 114 SHEET 5 AA2 9 PRO B 41 ILE B 44 1 N THR B 43 O LEU B 137 SHEET 6 AA2 9 GLU B 51 VAL B 61 -1 O VAL B 52 N ILE B 42 SHEET 7 AA2 9 GLY B 64 ILE B 71 -1 O THR B 68 N LEU B 56 SHEET 8 AA2 9 LEU B 5 PHE B 10 -1 N LEU B 5 O ILE B 71 SHEET 9 AA2 9 VAL B 149 GLY B 151 -1 O GLY B 151 N TYR B 6 CISPEP 1 LEU A 34 PRO A 35 0 4.33 CISPEP 2 LEU B 34 PRO B 35 0 1.49 CISPEP 3 ASN B 96 LEU B 97 0 -10.53 SITE 1 AC1 8 LEU A 79 TRP A 109 PRO A 192 HOH A 319 SITE 2 AC1 8 LEU B 47 PRO B 192 8OY B 201 8OY B 202 SITE 1 AC2 10 ARG A 82 LEU A 83 SER A 87 TRP A 109 SITE 2 AC2 10 LEU A 193 8OY A 201 ILE B 44 LEU B 140 SITE 3 AC2 10 ARG B 144 HOH B 344 SITE 1 AC3 14 TRP A 109 8OY A 201 ILE B 44 LEU B 79 SITE 2 AC3 14 LEU B 83 ALA B 90 TRP B 109 SER B 191 SITE 3 AC3 14 PRO B 192 LEU B 193 GLU B 194 THR B 195 SITE 4 AC3 14 HOH B 310 HOH B 345 CRYST1 67.400 92.860 118.930 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014837 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010769 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008408 0.00000